The Business Times
business-time-50

Malaysia gives conditional approval for use of Ronapreve Covid-19 treatment

google-preferred-sourceAdd BT as a preferred source
Published Tue, Dec 14, 2021 · 02:29 AM

    DeeperDive is a beta AI feature. Refer to full articles for the facts.

    [KUALA LUMPUR] Malaysia's health ministry said on Tuesday it has given conditional approval for the use of the single-dose antibody cocktail Ronapreve, developed by Regeneron and Roche, to treat Covid-19.

    It has also approved a request from Merck & Co for a clinical trial import license for its Covid-19 pill Molnupiravir, to be used as part of studies being conducted in Malaysia, the ministry said in a statement.

    REUTERS

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    MalaysiaCovid-19

    Share with us your feedback on BT's products and services

    Feedback

    TRENDING NOW

    Lim's pay package includes about S$3.6 million as salary and around S$3.9 million as bonus, indicates the company's annual report.

    Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025

    Chinese Foreign Minister Wang Yi stopped short of explicitly naming the US or Israel as aggressors, a telling omission from a country that otherwise speaks with little diplomatic timidity.

    Beijing’s calculated silence on the Iran war 

    Those aged below 30 account for the largest share of overqualification.

    More workers in Singapore opt for jobs for which they are overqualified: MOM, NTUC studies

    While residential property has delivered solid gains, observers say other assets such as equities often outpace it over the longer term.

    Higher costs, lower returns: Why are Singaporeans still betting on real estate?

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More